Skip to main content
. 2022 Nov 9;11(22):3569. doi: 10.3390/foods11223569

Figure 4.

Figure 4

(a) PCA of endo-metabolites of Hep G2 cells treated with GNR-L for different amounts of time (GNR-L-12 h, GNR-L-24 h). PCA of endo-metabolites of Hep G2 cells for (b) GNR-L-12 h and (c) GNR-L-24 h. Volcano plots of endo-metabolites of Hep G2 cells treated with (d) GNR-L-12 h and (e) GNR-L-24 h. (f) Venn diagram of statistically significant changed metabolites of Hep G2 cells for GNR-L-12 h and GNR-L-24 h groups. Heatmap of statistically significant changed metabolites of Hep G2 cells treated with (g) GNR-L-12 h and (h) GNR-L-24 h. The statistically significant changed metabolites were selected if p value was <0.05 and fold change value was >2 or <0.5.